CAMBRIDGE, Mass., August 26, 2024--(BUSINESS WIRE)--Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, today announced that its Board of ...

Christian Howell. [Image courtesy of Cognito Therapeutics] Cognito Therapeutics announced today that its board of directors appointed Christian Howell as its new CEO. Howell, who joined the ...

[Image courtesy of Cognito Therapeutics] Cognito Therapeutics today announced treatment results from an open-label extension study of its Alzheimer’s treating neuromodulation system. The ...

(Cognito Therapeutics) The Hope study will task upwards of 400 people with mild to moderate Alzheimer’s with using the noninvasive device at home every day for 12 months, throughout which they ...

And the improvements were particularly pronounced in the entorhinal region of the brain, where the Cognito users saw white matter increase by more than 5%, compared to a 7.6% volume loss for the ...

Cognito Forms is a game-changer, automating administrative work and streamlining business processes. Its powerful data collection and user-friendly interface empower global innovators. With both ...

A rendering of Cognito’s non-invasive neuromodulation device. Credit: Business Wire / Cognito Therapeutics. Cognito Therapeutics has raised $73m in a Series B financing round to advance its home-based ...

One startup is testing whether a "disco" of light and sound can slow the disease in patients. Cognito Therapeutics raised $73 million to test this theory in hundreds of people. For decades ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage neurotechnology company, announced today the first patient enrollment in its US pivotal study (HOPE), designed to ...

Integrated communications specialist Cognito has bolstered its Singapore and Hong Kong offices with two new senior promotions, of which Emma Arora (pictured left) is promoted to managing director ...